FOXP1 is a forkhead box transcription factor that functions as a critical regulator of cellular differentiation and inflammatory responses across multiple tissues. In embryonic stem cells, FOXP1 promotes pluripotency by stimulating expression of self-renewal factors while suppressing differentiation-associated genes, with distinct DNA-binding specificity for sequences like 5'-CGATACAA-3' 1. Beyond stem cell biology, FOXP1 plays essential roles in tissue homeostasis: it regulates ovarian aging by inhibiting CDKN1A transcription, with FOXP1 decline contributing to age-related ovarian insufficiency 2, and suppresses vascular inflammation by restraining NLRP3 inflammasome signaling in endothelial cells 3. In skeletal muscle, FOXP1 negatively regulates myogenic differentiation through the Arih2 axis, with elevated FOXP1 driving cancer cachexia and disrupting circadian transcription patterns associated with muscle wasting 4, 5. Pathologically, FOXP1 dysregulation facilitates tumor immune escape: in cervical cancer, FOXP1 promotes glycolytic reprogramming and immunosuppression 6, while EBV-encoded miRNAs inhibit FOXP1 to enhance PD-L1 expression in nasopharyngeal and gastric carcinomas 7. Additionally, FOXP1+ regulatory T cells accumulate in lung cancer in response to apCAF-derived PD-L2, hindering immunotherapy efficacy 8. Mutations in FOXP1 are associated with intellectual developmental disorder and autism spectrum features 9.